Abstract: This study was conducted to evaluate the effectiveness of the holiday food safety campaign, "The Story of Your Dinner," launched in 2016 by the Partnership for Food Safety Education. The campaign was designed to change knowledge, risk perception, and perceived behavioral control ideas among U.S. consumers. Results from the study, conducted from 2016 through 2018, were analyzed overall and among specific demographic groups. For respondents from all 3 years, overall knowledge significantly increased from presurvey to postsurvey. Survey findings indicated that after viewing the educational intervention, adult respondents were significantly more confident in their ability to use a food thermometer while cooking small cuts of meat and poultry and developed a significantly higher perception of the risk of suffering from foodborne illness. The educational intervention was more effective for changing risk perception and perceived behavioral control among some demographic groups. Respondent risk perception and perceived behavioral control significantly increased in more categories for adolescents than for adults. Consumers tended to overestimate their safe food handling practices. Prior to the educational intervention, adult respondents rated themselves highly (5.49 ± 1.64 of 7.00) on their confidence in cooking meat and poultry that is safe to eat. However, these respondents were less comfortable complying with the safe food handling practice of using a thermometer on small (4.47 ± 1.98) and large (4.61 ± 2.02) cuts of meat and poultry. More educational interventions are needed to improve compliance with safe food handling in home kitchens. Future studies will be conducted to identify and address barriers to food safety behavioral change among various population groups.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4315/0362-028X.JFP-19-329 | DOI Listing |
Cytotherapy
November 2024
Department of Translational and Precision Medicine, University of Rome, Rome, Italy. Electronic address:
Cellular and gene therapy (CGT) products have emerged as a popular approach in regenerative medicine, showing promise in treating various pancreatic and liver diseases in numerous clinical trials. Before these therapies can be tested in human clinical trials, it is essential to evaluate their safety and efficacy in relevant animal models. Such preclinical testing is often required to obtain regulatory approval for investigational new drugs.
View Article and Find Full Text PDFAm J Sports Med
January 2025
Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Background: Selective androgen receptor modulators (SARMs) are small-molecule compounds that exert agonist and antagonist effects on androgen receptors in a tissue-specific fashion. Because of their performance-enhancing implications, SARMs are increasingly abused by athletes. To date, SARMs have no Food and Drug Administration approved use, and recent case reports associate the use of SARMs with deleterious effects such as drug-induced liver injury, myocarditis, and tendon rupture.
View Article and Find Full Text PDFSci Rep
January 2025
Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, College of Food Science and Engineering, Inner Mongolia Agricultural University, Hohhot, 010018, China.
Aflatoxin M1 (AFM1) is known to be carcinogenic, mutagenic, and teratogenic and poses a serious threat to food safety and human health, which makes its surveillance critical. In this study, an indirect competitive ELISA (icELISA) based on a nanobody (Nb M4) was developed for the sensitive and rapid detection of AFM1 in dairy products. In our previous work, Nb M4 was screened from a Bactrian-camel-immunized phage-displayed library.
View Article and Find Full Text PDFActa Vet Scand
January 2025
Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Grønnegårdsvej 2, 1870, Frederiksberg C, Denmark.
Background: Prevention of iron deficiency in suckling piglets by intramuscular injection of a standardized amount of iron dextran or gleptoferron in the first days of life can lead to over- or underdosage with respective health risks. Currently, combined iron products containing an active substance against coccidia are also used on farms. When using a combination product targeting two diseases, an adjustment of the necessary amount of iron to prevent anaemia in the frame of a farm-specific treatment protocol is not possible.
View Article and Find Full Text PDFBMC Geriatr
January 2025
Deputy Director of the Health and Social Care Workforce Research Unit (HSCWRU), The Policy Institute, King's College London, 22 Kings Way, London, WC2B 6LE, England.
Background: Over the past decades, self-directed models of care have been implemented throughout the world to support older people, including those with dementia, to live at home. However, there is limited information about how self-directed home care is experienced by older people with cognitive impairment and dementia, and how their thinking informs their care choices and quality of life.
Methods: We used the ASCOT-Easy Read, a staggered reveal method, talk aloud techniques, probing questions, and physical assistance to support users of self-directed home care in Australia with cognitive impairment and dementia to discuss their Social Care Related Quality of Life (SCRQoL).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!